Empowered Funds
TNXP icon

Empowered Funds’s Tonix Pharmaceuticals TNXP Stock Holding History

Empowered Funds’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$192K Buy
+19,673
New +$232K ﹤0.01% 2276

Other funds holding TNXP

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
JHC
Jones Hill Capital New York $589M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Empowered Funds's TNXP Position: Q3 2026 in Review

Empowered Funds opened a new position in Tonix Pharmaceuticals (TNXP) in Q3 2026: 19,673 shares worth $192K. The stake represents ﹤0.01% of the portfolio and ranks #2276 among its holdings.

76 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • Empowered Funds held 19,673 shares of Tonix Pharmaceuticals worth $192K as of Q3 2026.
  • Tonix Pharmaceuticals was a new Empowered Funds position in Q3 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2276 holding.
  • 76 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.